175 related articles for article (PubMed ID: 1349435)
1. Comparative studies of sulpiride and classical neuroleptics on induction of catalepsy, locomotor activity, and brain dopamine metabolism in mice.
Fujiwara H
Pharmacol Biochem Behav; 1992 Feb; 41(2):301-8. PubMed ID: 1349435
[TBL] [Abstract][Full Text] [Related]
2. Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain.
Karolewicz B; Antkiewicz-Michaluk L; Michaluk J; Vetulani J
Eur J Pharmacol; 1996 Oct; 313(3):181-6. PubMed ID: 8911913
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of the pharmacological properties of sultopride sulpiride and other antipsychotic drugs: influence of sultopride, sulpiride and other antipsychotic drugs on spontaneous locomotor activity and changes in locomotor activity induced by apomorphine and clonidine in mice].
Horikomi K; Fujita M
Yakubutsu Seishin Kodo; 1986 Sep; 6(3):339-52. PubMed ID: 2880435
[TBL] [Abstract][Full Text] [Related]
4. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
Ossowska K; Karcz M; Wardas J; Wolfarth S
Eur J Pharmacol; 1990 Jul; 182(2):327-34. PubMed ID: 1975782
[TBL] [Abstract][Full Text] [Related]
5. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
Zetterström T; Sharp T; Ungerstedt U
Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
[TBL] [Abstract][Full Text] [Related]
6. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.
Hillegaart V; Ahlenius S; Magnusson O; Fowler CJ
Pharmacol Biochem Behav; 1987 May; 27(1):159-64. PubMed ID: 3615537
[TBL] [Abstract][Full Text] [Related]
7. Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis.
Imperato A; Di Chiara G
J Neurosci; 1985 Feb; 5(2):297-306. PubMed ID: 2857776
[TBL] [Abstract][Full Text] [Related]
8. Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats.
Jelovac N; Sikiric P; Rucman R; Petek M; Marovic A; Perovic D; Seiwerth S; Mise S; Turkovic B; Dodig G; Miklic P; Buljat G; Prkacin I
Eur J Pharmacol; 1999 Aug; 379(1):19-31. PubMed ID: 10499368
[TBL] [Abstract][Full Text] [Related]
9. Effects of subchronic haloperidol and sulpiride on regional brain dopamine metabolism in the rat.
Lindefors N; Sharp T; Ungerstedt U
Eur J Pharmacol; 1986 Oct; 129(3):401-4. PubMed ID: 3780852
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
Costall B; Naylor RJ
Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of sulpiride and haloperidol on dopamine turnover in the rat brain.
Imazu Y; Kobayashi K; Shohmori T
Neurochem Res; 1989 May; 14(5):459-64. PubMed ID: 2747836
[TBL] [Abstract][Full Text] [Related]
12. Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
Costall B; Naylor RJ
Psychopharmacologia; 1975 Jul; 43(1):69-74. PubMed ID: 1172258
[TBL] [Abstract][Full Text] [Related]
13. Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone.
Nakai S; Hirose T; Uwahodo Y; Imaoka T; Okazaki H; Miwa T; Nakai M; Yamada S; Dunn B; Burris KD; Molinoff PB; Tottori K; Altar CA; Kikuchi T
Eur J Pharmacol; 2003 Jul; 472(1-2):89-97. PubMed ID: 12860477
[TBL] [Abstract][Full Text] [Related]
14. The orexin-1 antagonist SB-334867 blocks antipsychotic treatment emergent catalepsy: implications for the treatment of extrapyramidal symptoms.
Rasmussen K; Hsu MA; Noone S; Johnson BG; Thompson LK; Hemrick-Luecke SK
Schizophr Bull; 2007 Nov; 33(6):1291-7. PubMed ID: 17660489
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term dosing with tiapride on brain dopamine receptors and metabolism in rats. Comparative study with sulpiride and haloperidol.
Satoh H; Kuwaki T; Shirakawa K; Kohjimoto Y; Ono T; Shibayama F; Nomura Y
Jpn J Pharmacol; 1987 Aug; 44(4):393-403. PubMed ID: 3682405
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
Van Ree JM; Elands J; Király I; Wolterink G
Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
[TBL] [Abstract][Full Text] [Related]
17. [Effects of risperidone on catalepsy and cerebral dopamine, serotonin and GABA metabolism in the rat: comparison with haloperidol].
Kikumoto O; Okamoto Y; Hayakawa H; Yokota N; Kawai K; Motohashi N; Yamawaki S
Yakubutsu Seishin Kodo; 1993 Feb; 13(1):39-42. PubMed ID: 7686319
[TBL] [Abstract][Full Text] [Related]
18. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
Ogren SO; Hall H; Köhler C; Magnusson O; Lindbom LO; Angeby K; Florvall L
Eur J Pharmacol; 1984 Jul; 102(3-4):459-74. PubMed ID: 6149133
[TBL] [Abstract][Full Text] [Related]
19. Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.
Halperin R; Guerin JJ; Davis KL
Psychopharmacology (Berl); 1989; 98(3):386-91. PubMed ID: 2568659
[TBL] [Abstract][Full Text] [Related]
20. Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics.
Barghon R; Protais P; Colboc O; Costentin J
Neurosci Lett; 1981 Nov; 27(1):69-73. PubMed ID: 6120489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
